Search by Drug Name or NDC
NDC 00409-1660-20 Precedex 4 ug/mL Details
Precedex 4 ug/mL
Precedex is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is DEXMEDETOMIDINE HYDROCHLORIDE.
Product Information
| NDC | 00409-1660 |
|---|---|
| Product ID | 0409-1660_ffeff440-1322-4851-921f-e5b74e675fbf |
| Associated GPIs | 60206030202040 60206030202010 60206030202020 |
| GCN Sequence Number | 070877 |
| GCN Sequence Number Description | dexmedetomidine in 0.9 % NaCl INFUS. BTL 400MCG/100 INTRAVEN |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 34539 |
| HICL Sequence Number | 040230 |
| HICL Sequence Number Description | DEXMEDETOMIDINE HCL IN 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Brand |
| Proprietary Name | Precedex |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | ug/mL |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021038 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-1660-20 (00409166020)
| NDC Package Code | 0409-1660-20 |
|---|---|
| Billing NDC | 00409166020 |
| Package | 10 VIAL in 1 CARTON (0409-1660-20) / 20 mL in 1 VIAL (0409-1660-22) |
| Marketing Start Date | 2015-01-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |